The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
The Scientist
Most Recent
Human-specific duplications of a gene involved in brain development may have contributed to our species’ unique intelligence.
Human embryonic stem cells swiftly kill themselves in response to DNA damage.
Genes that react to cellular sugar content are regulated by a long non-coding RNA via an unexpected mechanism
From accounts of deformed animals to scratch-and-sniff technology, Robert Boyle's early contributions to the Royal Society of London were prolific and wide ranging.
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
New work on salicylate, a natural component of aspirin, suggests that activation of the energy-sensing AMP kinase may underlie some of aspirin’s health benefits.
A novel antibody with a powerful affinity for cocaine shows promise in reversing the deadly effects of an overdose.
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Large molecules are more likely to make it to market these days than small molecules, according to new reports.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
